ICU Archive — Page 1 of 2
-
June 21, 2021
Dexmedetomidine and delirium
The sedative dexmedetomidine, when administered during or after heart surgery, is associated with postoperative delirium and adverse outcomes. -
April 1, 2021
COVID-19 met with intensive teamwork
Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts. -
February 2, 2021
Study finds recommended ICU sedatives equally safe, effective
Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia. -
July 22, 2020
Study to explore how COVID affects cognition over time
The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD). -
June 4, 2020
Fleming reflects on a life of love, purpose after terminal cancer diagnosis
A month before his 49th birthday, Geoffrey Fleming, MD, had a biopsy of his liver to diagnose an unidentified metastatic disease that he already knew was “something bad.” -
May 21, 2020
Rounding based on acuity helps preserve attention of clinicians
Multidisciplinary teams conducting daily rounds in intensive care units will typically work their way down hallways, going from one patient to the next based on spatial proximity. -
October 9, 2019
Vaccine study seeks to halt flu’s most severe side effects
Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.